ClearBridge Investments - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q2 2020$6,000
+20.0%
9770.0%0.00%
Q1 2020$5,000
-50.0%
977
-3.2%
0.00%
Q4 2019$10,000
+66.7%
1,0090.0%0.00%
Q3 2019$6,000
-99.9%
1,009
-99.8%
0.00%
-100.0%
Q2 2019$4,466,000
-35.0%
490,807
-0.9%
0.00%
-33.3%
Q1 2019$6,869,000
-11.6%
495,227
+0.6%
0.01%
-25.0%
Q4 2018$7,768,000
-18.5%
492,288
-0.1%
0.01%0.0%
Q3 2018$9,535,000
+165.2%
492,757
+0.0%
0.01%
+166.7%
Q2 2018$3,596,000
+134.3%
492,567
-1.3%
0.00%
+200.0%
Q1 2018$1,535,000
-4.7%
499,273
+0.0%
0.00%0.0%
Q4 2017$1,610,000
-33.5%
499,193
+0.0%
0.00%
-50.0%
Q3 2017$2,420,000
-7.0%
499,058
-0.2%
0.00%
-33.3%
Q2 2017$2,601,000
+4.2%
500,280
+0.2%
0.00%0.0%
Q1 2017$2,497,000
+2.1%
499,476
+0.1%
0.00%0.0%
Q4 2016$2,446,000
-26.5%
499,213
+0.1%
0.00%
-25.0%
Q3 2016$3,328,000
+36.3%
498,934
-1.1%
0.00%
+33.3%
Q2 2016$2,441,000
-0.3%
504,279
+0.5%
0.00%0.0%
Q1 2016$2,448,000
-43.5%
501,669
+0.5%
0.00%
-40.0%
Q4 2015$4,331,000
-40.4%
499,016
+0.1%
0.01%
-44.4%
Q3 2015$7,264,000
-12.5%
498,559
+0.1%
0.01%0.0%
Q2 2015$8,303,000
-24.0%
498,066
-0.2%
0.01%
-18.2%
Q1 2015$10,922,000
+0.9%
499,187
-0.0%
0.01%0.0%
Q4 2014$10,822,000
+58.3%
499,403
+25.5%
0.01%
+37.5%
Q3 2014$6,838,000397,7860.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders